Published in Curr Cardiol Rep on October 01, 2012
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol (2006) 5.58
Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation (2000) 4.08
A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation (1997) 3.13
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation (2005) 2.80
Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol (2010) 2.75
Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol (2012) 2.59
Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol (2004) 2.39
Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation (2010) 2.26
Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia. Heart Rhythm (2006) 2.18
Electrocardiographic recognition of the epicardial origin of ventricular tachycardias. Circulation (2004) 2.05
Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol (2009) 1.96
Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol (2009) 1.91
Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation (2003) 1.74
Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol (2010) 1.73
Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation? Heart Rhythm (2010) 1.72
ECG criteria to identify epicardial ventricular tachycardia in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol (2009) 1.67
Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.63
Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol (1987) 1.58
Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. J Am Coll Cardiol (1996) 1.44
Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of Valsalva: electrophysiological characteristics, catheter ablation, and identification from the 12-lead electrocardiogram. Circulation (2006) 1.39
Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol (2010) 1.35
Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol (1986) 1.32
Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm (2010) 1.27
Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.27
Site-specific twelve-lead ECG features to identify an epicardial origin for left ventricular tachycardia in the absence of myocardial infarction. Heart Rhythm (2007) 1.21
Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol (1984) 1.19
Characterization of the phrenic nerve course within the epicardial substrate of patients with nonischemic cardiomyopathy and ventricular tachycardia. Heart Rhythm (2008) 0.99
Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications. Heart Rhythm (2011) 0.94
Assessing epicardial substrate using intracardiac echocardiography during VT ablation. Circ Arrhythm Electrophysiol (2011) 0.93
Isolated potentials and pace-mapping as guides for ablation of ventricular tachycardia in various types of nonischemic cardiomyopathy. J Cardiovasc Electrophysiol (2010) 0.83
Management of hemopericardium related to percutaneous epicardial access, mapping, and ablation. Heart Rhythm (2011) 0.77
Sinus rhythm ECG criteria associated with basal-lateral ventricular tachycardia substrate in patients with nonischemic cardiomyopathy. J Cardiovasc Electrophysiol (2011) 0.77
Ventricular tachycardia originating from the aortic sinus cusp in patients with idiopathic dilated cardiomyopathy. Heart Rhythm (2010) 0.77
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol (2012) 5.46
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol (2005) 3.85
Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol (2013) 2.58
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol (2005) 2.34
Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation (2010) 2.26
Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia. Heart Rhythm (2006) 2.18
Impact of local ablation on interconnected channels within ventricular scar: mechanistic implications for substrate modification. Circ Arrhythm Electrophysiol (2013) 2.15
The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis (2008) 2.09
Use of thoracic epidural anesthesia for management of electrical storm: a case report. Heart Rhythm (2005) 2.07
Sympathetic innervation of the anterior left ventricular wall by the right and left stellate ganglia. Heart Rhythm (2012) 1.93
Functional pace-mapping responses for identification of targets for catheter ablation of scar-mediated ventricular tachycardia. Circ Arrhythm Electrophysiol (2012) 1.89
Functional characterization of atrial electrograms in sinus rhythm delineates sites of parasympathetic innervation in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol (2007) 1.83
Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Heart Rhythm (2012) 1.77
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol (2014) 1.64
Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing Clin Electrophysiol (2014) 1.60
Mode and mechanisms of death after orthotopic heart transplantation. Heart Rhythm (2009) 1.60
Percutaneous intrapericardial echocardiography during catheter ablation: a feasibility study. Heart Rhythm (2006) 1.57
Catheter ablation of right ventricular outflow tract tachycardia: value of defining coronary anatomy. J Cardiovasc Electrophysiol (2006) 1.57
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol (2014) 1.53
Impedance monitoring during catheter ablation of atrial fibrillation. Heart Rhythm (2005) 1.49
Catheter ablation of atrial fibrillation. Circulation (2012) 1.47
A case of a human ventricular fibrillation rotor localized to ablation sites for scar-mediated monomorphic ventricular tachycardia. Heart Rhythm (2013) 1.46
Catheter ablation of typical atrial flutter in severe pulmonary hypertension. J Cardiovasc Electrophysiol (2012) 1.45
The Cardiac Atlas Project--an imaging database for computational modeling and statistical atlases of the heart. Bioinformatics (2011) 1.44
Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot. Circ Arrhythm Electrophysiol (2013) 1.43
Unipolar and bipolar electrogram characteristics predict exit block during pulmonary vein antral isolation. Pacing Clin Electrophysiol (2012) 1.43
Panoramic electrophysiological mapping but not electrogram morphology identifies stable sources for human atrial fibrillation: stable atrial fibrillation rotors and focal sources relate poorly to fractionated electrograms. Circ Arrhythm Electrophysiol (2013) 1.40
Supraventricular tachycardia after orthotopic cardiac transplantation. J Am Coll Cardiol (2008) 1.35
Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol (2011) 1.35
Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol (2010) 1.35
Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol (2012) 1.32
Distinguishing epicardial fat from scar: analysis of electrograms using high-density electroanatomic mapping in a novel porcine infarct model. Heart Rhythm (2009) 1.24
Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J (2005) 1.24
A novel method for preventing phrenic nerve injury during catheter ablation. Heart Rhythm (2006) 1.17
Percutaneous epicardial mapping during ablation of difficult accessory pathways as an alternative to cardiac surgery. Heart Rhythm (2004) 1.15
Distribution of late potentials within infarct scars assessed by ultra high-density mapping. Heart Rhythm (2010) 1.15
Radiofrequency current delivery via transseptal needle to facilitate septal puncture. Heart Rhythm (2007) 1.15
Irreversible intrapulmonary vascular changes after pulmonary vein stenosis complicating catheter ablation for atrial fibrillation. Cardiovasc Pathol (2007) 1.13
A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J (2006) 1.11
Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care (2006) 1.10
Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magn Reson Imaging (2010) 1.09
Ultra high-density multipolar mapping with double ventricular access: a novel technique for ablation of ventricular tachycardia. J Cardiovasc Electrophysiol (2011) 1.09
Pleuropericardial fistula formation after prior epicardial catheter ablation for ventricular tachycardia. Circ Arrhythm Electrophysiol (2012) 1.08
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm (2014) 1.08
Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction. Am J Physiol Heart Circ Physiol (2012) 1.06
Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: neural remodeling in a spatial context. Am J Physiol Heart Circ Physiol (2013) 1.05
Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med (2006) 1.05
Signal-averaged electrocardiogram in Ebstein's anomaly. Am J Cardiol (2004) 1.04
Intracardiac echocardiography during interventional and electrophysiological cardiac catheterization. Circulation (2009) 1.04
Extracardiac neural remodeling in humans with cardiomyopathy. Circ Arrhythm Electrophysiol (2012) 1.02
Characterization of myocardial scars: electrophysiological imaging correlates in a porcine infarct model. Heart Rhythm (2011) 1.01
Autonomic Regulation Therapy in Heart Failure. Curr Heart Fail Rep (2015) 1.01
Catheter ablation utilizing remote magnetic navigation: a review of applications and outcomes. Pacing Clin Electrophysiol (2012) 1.01
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol (2010) 1.00
Epicardial interventions in electrophysiology. Circulation (2012) 1.00
NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J (2006) 0.99
Transient left recurrent laryngeal nerve palsy following catheter ablation of atrial fibrillation. Heart Rhythm (2005) 0.97
Hybrid procedures for epicardial catheter ablation of ventricular tachycardia: value of surgical access. Heart Rhythm (2010) 0.97
Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. Radiology (2013) 0.96
A new electrocardiographic marker for sympathetic nerve stimulation: modulation of repolarization by stimulation of stellate ganglia. J Electrocardiol (2011) 0.94
Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. J Card Fail (2006) 0.94
Forward-looking intracardiac ultrasound imaging using a 1-D CMUT array integrated with custom front-end electronics. IEEE Trans Ultrason Ferroelectr Freq Control (2008) 0.94
Neural remodeling and myocardial infarction: the stellate ganglion as a double agent. J Am Coll Cardiol (2012) 0.94
Cardiomyopathy is associated with structural remodelling of heart valve extracellular matrix. Eur Heart J (2009) 0.92
Modulation of regional dispersion of repolarization and T-peak to T-end interval by the right and left stellate ganglia. Am J Physiol Heart Circ Physiol (2013) 0.92
Idiopathic massive myocardial calcification: a case report and review of the literature. Cardiovasc Pathol (2010) 0.91
Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol (2005) 0.91
Functional differences between junctional and extrajunctional adrenergic receptor activation in mammalian ventricle. Am J Physiol Heart Circ Physiol (2012) 0.90
Azygos vein lead implantation: a novel adjunctive technique for implantable cardioverter defibrillator placement. J Cardiovasc Electrophysiol (2004) 0.90
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace (2014) 0.90
The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail (2005) 0.89
Safety and outcomes of cryoablation for ventricular tachyarrhythmias: results from a multicenter experience. Heart Rhythm (2011) 0.88
Left ventricular lead stabilization utilizing a coronary stent. Pacing Clin Electrophysiol (2006) 0.88
Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility. Heart Rhythm (2010) 0.87
Alterations in ion channel physiology in diabetic cardiomyopathy. Endocrinol Metab Clin North Am (2006) 0.87
Transconduit puncture for catheter ablation of atrial tachycardia in a patient with extracardiac Fontan palliation. Heart Rhythm (2009) 0.87
Changes and predictive value of dispersion of repolarization parameters for appropriate therapy in patients with biventricular implantable cardioverter-defibrillators. Heart Rhythm (2007) 0.86
Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely. Circulation (2009) 0.86
Accuracy of combined endocardial and epicardial electroanatomic mapping of a reperfused porcine infarct model: a comparison of electrofield and magnetic systems with histopathologic correlation. Heart Rhythm (2010) 0.85
Left ventricular endocardial lead placement using a modified transseptal approach. J Cardiovasc Electrophysiol (2004) 0.85
The feasibility of using thermal strain imaging to regulate energy delivery during intracardiac radio-frequency ablation. IEEE Trans Ultrason Ferroelectr Freq Control (2011) 0.85
Quantitative localization of premature ventricular contractions using myocardial activation ECGI from the standard 12-lead electrocardiogram. J Electrocardiol (2013) 0.85
A clinical and biochemical critical pathway for the evaluation of patients with suspected acute congestive heart failure: The ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) algorithm. Crit Pathw Cardiol (2004) 0.85
Our approach to minimize risk of epicardial access: standard techniques with the addition of electroanatomic mapping guidance. J Cardiovasc Electrophysiol (2012) 0.84
Diagnostic maneuver during narrow-complex tachycardia: what is the arrhythmia mechanism? Heart Rhythm (2008) 0.84
Bilateral cardiac sympathetic denervation: why, who and when? Expert Rev Cardiovasc Ther (2012) 0.84
Percutaneous interventricular septal access in a patient with aortic and mitral mechanical valves: a novel technique for catheter ablation of ventricular tachycardia. Heart Rhythm (2013) 0.84